TABLE 1.
Virus | Growtha | Pol proteinb | Pol at focic | PML at focid |
---|---|---|---|---|
KOS | +++ | +++ | +++ | +++ |
V462A | +++ | +++ | +++ | +++ |
Arar9 | +++ | +++ | +++ | +++ |
615.8 | +++ | +++ | +++ | +++ |
F891C | +++ | +++ | +++ | +++ |
PAAr5 | +++ | +++ | +++ | +++ |
Y7 | +++ | +++ | +++ | +++ |
YD12 | +++ | +++ | +++++ | +++ |
HP66 | — | — | — | — |
ΔX17 | — | — | — | — |
ΔX14 | — | — | — | — |
ΔS1.1 | — | — | — | — |
7E4A | — | — | — | — |
6C4 | — | ++ | — | — |
E460D | — | +++ | — | — |
G464V | — | +++ | — | — |
tsC4 | — | +++ | — | — |
tsC7 | — | +++ | + | ++ |
Indicates ability of mutant virus to form plaques on noncomplementing cell lines. +++++, higher than wild-type levels; +++, wild-type levels; ++, slightly lower than wild-type levels; +, significantly lower than wild-type levels; —, undetectable.
Indicates ability of mutant virus to synthesize Pol protein detectable by Western blot analysis.
Indicates whether Pol protein is detectable at viral prereplicative sites.
Indicates whether PML protein is detectable at viral prereplicative sites.